Predicting the probability of significant prostate cancer in Japanese men with serum prostate-specific antigen less than 10 ng/mL: Development of a novel pre-biopsy nomogram: Original article

Takashi Ohigashi, Kent Kanao, Ryuichi Mizuno, Eiji Kikuchi, June Nakashima, Mototsugu Oya

研究成果: Article

6 引用 (Scopus)

抄録

Objectives: To develop and assess a new nomogram incorporating pre-biopsy clinical data to predict significant prostate cancer in Japanese men with a serum prostate-specific antigen (PSA) level of less than 10 ng/mL. Methods: We collected pre-biopsy data from 620 men with a serum total PSA of less than 10 ng/mL. They included 491 men with a negative biopsy and 129 men who were confirmed to have histological prostate cancer and subsequently underwent radical prostatectomy. Clinically significant tumors were defined as those with a tumor volume larger than 0.5 mL and/or a Gleason score of 7 or more. Results: One hundred and seven prostatectomy patients had clinically significant cancers. Stepwise multivariate logistic regression analysis showed that digital rectal examination findings, PSA adjusted for transition zone volume and free-to-total PSA ratio were the significant independent predictors of significant cancers (P < 0.0001). Using these pre-biopsy independent factors, a nomogram was developed to predict significant cancers. According to a receiver operating characteristics analysis, the nomogram showed an area under the curve of 0.831. Conclusion: This represents the first nomogram to predict the probability of clinically significant cancers before biopsy. This tool is most likely to be useful in the management of patients with moderate to elevated PSA.

元の言語English
ページ(範囲)274-280
ページ数7
ジャーナルInternational Journal of Urology
17
発行部数3
DOI
出版物ステータスPublished - 2010 3

Fingerprint

Nomograms
Prostate-Specific Antigen
Prostatic Neoplasms
Biopsy
Serum
Neoplasms
Prostatectomy
Digital Rectal Examination
Neoplasm Grading
Tumor Burden
ROC Curve
Area Under Curve
Logistic Models
Regression Analysis

ASJC Scopus subject areas

  • Urology

これを引用

@article{5efa01f47dcb4aad8739c4f91c7aef86,
title = "Predicting the probability of significant prostate cancer in Japanese men with serum prostate-specific antigen less than 10 ng/mL: Development of a novel pre-biopsy nomogram: Original article",
abstract = "Objectives: To develop and assess a new nomogram incorporating pre-biopsy clinical data to predict significant prostate cancer in Japanese men with a serum prostate-specific antigen (PSA) level of less than 10 ng/mL. Methods: We collected pre-biopsy data from 620 men with a serum total PSA of less than 10 ng/mL. They included 491 men with a negative biopsy and 129 men who were confirmed to have histological prostate cancer and subsequently underwent radical prostatectomy. Clinically significant tumors were defined as those with a tumor volume larger than 0.5 mL and/or a Gleason score of 7 or more. Results: One hundred and seven prostatectomy patients had clinically significant cancers. Stepwise multivariate logistic regression analysis showed that digital rectal examination findings, PSA adjusted for transition zone volume and free-to-total PSA ratio were the significant independent predictors of significant cancers (P < 0.0001). Using these pre-biopsy independent factors, a nomogram was developed to predict significant cancers. According to a receiver operating characteristics analysis, the nomogram showed an area under the curve of 0.831. Conclusion: This represents the first nomogram to predict the probability of clinically significant cancers before biopsy. This tool is most likely to be useful in the management of patients with moderate to elevated PSA.",
keywords = "Diagnosis, Prostate, Prostate-specific antigen, Prostatic neoplasms",
author = "Takashi Ohigashi and Kent Kanao and Ryuichi Mizuno and Eiji Kikuchi and June Nakashima and Mototsugu Oya",
year = "2010",
month = "3",
doi = "10.1111/j.1442-2042.2010.02453.x",
language = "English",
volume = "17",
pages = "274--280",
journal = "International Journal of Urology",
issn = "0919-8172",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Predicting the probability of significant prostate cancer in Japanese men with serum prostate-specific antigen less than 10 ng/mL

T2 - Development of a novel pre-biopsy nomogram: Original article

AU - Ohigashi, Takashi

AU - Kanao, Kent

AU - Mizuno, Ryuichi

AU - Kikuchi, Eiji

AU - Nakashima, June

AU - Oya, Mototsugu

PY - 2010/3

Y1 - 2010/3

N2 - Objectives: To develop and assess a new nomogram incorporating pre-biopsy clinical data to predict significant prostate cancer in Japanese men with a serum prostate-specific antigen (PSA) level of less than 10 ng/mL. Methods: We collected pre-biopsy data from 620 men with a serum total PSA of less than 10 ng/mL. They included 491 men with a negative biopsy and 129 men who were confirmed to have histological prostate cancer and subsequently underwent radical prostatectomy. Clinically significant tumors were defined as those with a tumor volume larger than 0.5 mL and/or a Gleason score of 7 or more. Results: One hundred and seven prostatectomy patients had clinically significant cancers. Stepwise multivariate logistic regression analysis showed that digital rectal examination findings, PSA adjusted for transition zone volume and free-to-total PSA ratio were the significant independent predictors of significant cancers (P < 0.0001). Using these pre-biopsy independent factors, a nomogram was developed to predict significant cancers. According to a receiver operating characteristics analysis, the nomogram showed an area under the curve of 0.831. Conclusion: This represents the first nomogram to predict the probability of clinically significant cancers before biopsy. This tool is most likely to be useful in the management of patients with moderate to elevated PSA.

AB - Objectives: To develop and assess a new nomogram incorporating pre-biopsy clinical data to predict significant prostate cancer in Japanese men with a serum prostate-specific antigen (PSA) level of less than 10 ng/mL. Methods: We collected pre-biopsy data from 620 men with a serum total PSA of less than 10 ng/mL. They included 491 men with a negative biopsy and 129 men who were confirmed to have histological prostate cancer and subsequently underwent radical prostatectomy. Clinically significant tumors were defined as those with a tumor volume larger than 0.5 mL and/or a Gleason score of 7 or more. Results: One hundred and seven prostatectomy patients had clinically significant cancers. Stepwise multivariate logistic regression analysis showed that digital rectal examination findings, PSA adjusted for transition zone volume and free-to-total PSA ratio were the significant independent predictors of significant cancers (P < 0.0001). Using these pre-biopsy independent factors, a nomogram was developed to predict significant cancers. According to a receiver operating characteristics analysis, the nomogram showed an area under the curve of 0.831. Conclusion: This represents the first nomogram to predict the probability of clinically significant cancers before biopsy. This tool is most likely to be useful in the management of patients with moderate to elevated PSA.

KW - Diagnosis

KW - Prostate

KW - Prostate-specific antigen

KW - Prostatic neoplasms

UR - http://www.scopus.com/inward/record.url?scp=77749285724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77749285724&partnerID=8YFLogxK

U2 - 10.1111/j.1442-2042.2010.02453.x

DO - 10.1111/j.1442-2042.2010.02453.x

M3 - Article

C2 - 20148990

AN - SCOPUS:77749285724

VL - 17

SP - 274

EP - 280

JO - International Journal of Urology

JF - International Journal of Urology

SN - 0919-8172

IS - 3

ER -